Cargando...
‘No evidence of disease activity’ – is it an appropriate surrogate in multiple sclerosis?
The increasing number of disease‐modifying treatments available for multiple sclerosis has broadened treatment options for patients, but also challenges clinicians to select the best therapy for each individual at the appropriate stage of the disease. Early prediction of treatment response still rem...
Gardado en:
| Publicado en: | Eur J Neurol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6099351/ https://ncbi.nlm.nih.gov/pubmed/29687559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.13669 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|